Patent ID: 9737579
Date: 2017-08-22
CPC Classifications: A61K,A61P,C12N,Y02A

Claim:
1. A method of treating or reducing the incidence of an infection caused by at least one of Staphylococcus aureus, Acinetobacter baumanni, Klebsiella pneumonia , and Escherichia coli in a subject in need thereof, said method comprising administering to said subject an effective amount of a pharmaceutical composition, said pharmaceutical composition comprising: a pharmaceutically acceptable carrier; and a purified bacteriophage having a genome which comprises at least 99% sequence identity to the nucleotide sequence selected from the group consisting of SEQ ID NO:1074, SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, and SEQ ID NO: 781, and having antibacterial activity against at least one of